Maria ChittyLopez

Pediatrician - Allergy/Immunology 🦓 ^Inborn Errors of Immunity/Gene Therapy^ 🧬. Tweets are my own and not the views of my employer

[Maria ChittyLopez @MariaCLopezMD]

@McDonalds @McDonalds we want @TIMPAYNESOL merchandise 🫶

[Maria ChittyLopez @MariaCLopezMD]

@Kohn_Lab @RocketPharma @CIRMnews Congratulations @Kohn_Lab incredible achievement for patients and families!

[U.S. FDA @US_FDA]

For patients with severe Leukocyte Adhesion Deficiency Type I (LAD-I), treatment options have been limited. A new gene therapy may offer hope through the FDA’s accelerated approval pathway. https://t.co/MosJOFGOuY

[FDA Biologics @FDACBER]

Today, the FDA approved the first cell-based gene therapy for the treatment of Wiskott-Aldrich Syndrome (WAS). https://t.co/9h9BRtqgwr

[kate sullivan @katesullimmuno]

Allergy Immunology course October 24.

[CHOP Research @CHOP_Research]

In a landmark scientific feat published in @NEJM, a @ChildrensPhila & @PennMedicine team treated the first patient with personalized #genetherapy, designed uniquely for newborn KJ, who was diagnosed with a rare #ureacycledisorder at birth. Learn more: https://t.co/aUS67Sncdy

[UCLA Broad Stem Cell @UCLAstemcell]

A new study in @NEJM reports that an investigational gene therapy restored immune function in 9 children with LAD-I, a rare & life-threatening immune disorder. Those children are now living symptom-free 2 years after treatment in clinical trials co-led by @Kohn_Lab @UCLA.

[Maria ChittyLopez @MariaCLopezMD]

>550

[International Union of Immunological Societies @iuis_online]

The 2024 IUIS Inborn Errors of Immunity (IEI) Classification has arrived! Explore our latest insights now at https://t.co/IqbLhAGPTq. Find the report under “Annual 2024 Report”!

[Celine Dion @celinedion]

I’m honored to have performed tonight, for the Paris 2024 Opening Ceremony, and so full of joy to be back in one of my very favorite cities! Most of all, I’m so happy to be celebrating these amazing athletes, with all their stories of sacrifice and determination, pain and perseverance. All of you have been so focused on your dream, and whether or not you take home a medal, I hope that being here means that it has come true for you! You should all be so proud, we know how hard you have worked to be the best of the best. Stay focused, keep going, my heart is with you! - Celine xx…

Photo: Laura Gilli

[Institute for Gene Therapies @gene_therapies]

.@gaucheralliance's Madelyn Schloss shares her perspective on #genetherapy at @gene_therapies & @alliancerm's recent #CapitolHill briefing on patient access to new innovations. View the full briefing here: https://t.co/RGTA3899tI

[Maria ChittyLopez @MariaCLopezMD]

@DrAshM2 @ClinImmSoc See you next year! :)

[National Human Genome Research Institute @genome_gov]

May the 4th be with you today! 🧬

[Maria ChittyLopez @MariaCLopezMD]

I am grateful for #CIS2024, a fantastic meeting to exchange ideas and review novel concepts.

[kate sullivan @katesullimmuno]

Our very own Maria Chitty Lopez shows off the LAD1 gene therapy data. Just incredible.

[Maria ChittyLopez @MariaCLopezMD]

@katesullimmuno Thank you for all your support @katesullimmuno

[The Nobel Prize @NobelPrize]

We're celebrating the International Day of Women and Girls in Science!

Let's look back on the life of Marie Skłodowska Curie: a Nobel Prize laureate who dedicated her life to science and became one of the world's greatest scientists.

#WomenInScience #NobelPrize

[AAAAI @AAAAI_org]

Acid-suppressive medication and antimicrobial use in infancy associated with food allergy and anaphylaxis according to new research being presented at the 2024 AAAAI Annual Meeting. #AAAAI24 #FoodAllergy
https://t.co/aOEH7rbaNu

[Maria ChittyLopez @MariaCLopezMD]

Best way to start your week! What a refreshing manuscript! 👍🏻

[Casanova Lab @casanova_lab]

Remarkable and entertaining introduction to the field of IEI by @HsiehElena @alexbolze & Joseph Hernandez:
Inborn errors of immunity illuminate mechanisms of human immunology and pave the road to precision medicine https://t.co/hIZL6aNtxq

[U.S. FDA @US_FDA]

Additionally, one of these therapies is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling an innovative advancement in the field of gene therapy.

[U.S. FDA @US_FDA]

Today we approved two milestone treatments - the first cell-based gene therapies to treat sickle cell disease in patients 12 years and older. https://t.co/az8lDdRyz0